Neoleukin Therapeutics Depreciation & Amortization 2011-2026 | NLTX

Annual Depreciation & Amortization Neoleukin Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.04 M	3.2 M	3.26 M	3.2 M	1.31 M	785 K	340 K	289 K	360 K	-	-	136 K	59.6 K	131 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
3.26 M	59.6 K	1.34 M

Quarterly Depreciation & Amortization Neoleukin Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
800 K	800 K	749 K	-	800 K	800 K	814 K	-	800 K	800 K	329 K	-	1.19 M	870 K	411 K	-	916 K	560 K	247 K	-	578 K	390 K	171 K	-	180 K	82 K	41 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	71.9 K	18.2 K	-	45.2 K	15.6 K	14.8 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.19 M	14.8 K	481 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	-	-	$ 2.06 B	France
Cumberland Pharmaceuticals CPIX	4.9 M	$ 3.12	-	$ 43.9 M	USA
Bausch Health Companies BHC	1.26 B	$ 5.8	1.4 %	$ 2.12 B	Canada
Harrow Health HROW	1.32 M	$ 38.15	2.83 %	$ 1.4 B	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.11	2.31 %	$ 119 M	Canada
Jupiter Wellness JUPW	654 K	-	-	$ 33.6 M	USA
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Evolus EOLS	7.51 M	$ 4.36	0.7 %	$ 281 M	USA
Emergent BioSolutions EBS	125 M	$ 8.34	1.21 %	$ 427 M	USA
Tilray TLRY	35.7 M	$ 7.0	4.17 %	$ 4.33 B	Canada
Organogenesis Holdings ORGO	13.6 M	$ 2.39	0.42 %	$ 315 M	USA
Pacira BioSciences PCRX	78.8 M	$ 24.32	1.06 %	$ 1.12 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Veru VERU	268 K	$ 2.4	1.05 %	$ 324 M	USA
ProPhase Labs PRPH	4.72 M	-	-	$ 5.07 M	USA
Viatris VTRS	2.74 B	$ 13.84	0.07 %	$ 16.6 B	USA
Relmada Therapeutics RLMD	1.26 K	$ 7.42	0.54 %	$ 293 M	USA
cbdMD YCBD	452 K	$ 0.75	1.28 %	$ 3.23 M	USA
Assertio Holdings ASRT	30 M	$ 18.1	0.44 %	$ 116 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	580 K	$ 1.03	1.98 %	$ 51.4 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	1.64 M	$ 8.59	2.38 %	$ 752 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 2.35	-	$ 2.92 M	USA
Zomedica Corp. ZOM	2.06 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	219 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	2.19 M	$ 0.91	-2.69 %	$ 32.7 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	1.5 M	$ 0.65	-	$ 2.79 M	China
TherapeuticsMD TXMD	384 K	$ 2.03	-0.98 %	$ 23.5 M	USA